Key facts
- It has raised $3.5M across 3 recorded rounds; the latest was Seed Round ($4.0M) in Jun 2026.
- Notable investors include Cultivation Capital, Early Light Ventures.
- VedaPointe has filed 2 Form Ds with the SEC since 2022, most recently Jul 2024 ($2.7M sold to 15 investors).
- Status: Privately Held (backing).
Investors
2- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for VedaPointe
Funding rounds
3 roundsAbout VedaPointe
Operator of a health-tech platform intended to align communication channels to facilitate new healthcare economic models. The company's platform offers a data ecosystem that uniquely expands and enhances the exchange of clinical and administrative healthcare data necessary to normalize value-based care in the revenue cycle management structure, enabling healthcare professionals to access strategic expertise that drives new value from the integration of clinical and administrative healthcare data.
- Sector
- Healthcare
- HQ
- Saint Louis, MO, United States
- Founded
- 2019
- Employees
- 29
- Website
- vedapointe.com/
- Ownership
- Privately Held (backing)
VedaPointe doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in VedaPointe shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on VedaPointe in its N-PORT filings yet. We sweep new filings monthly.